Skip to main content

Dr. Matthew Krummel - Dominant and reactive archetypes of immunity in tumors

Matthew F. Krummel

Department of Pathology & ImmunoX Initiative, UCSF, San Francisco, CA

Dominant and reactive archetypes of immunity in tumors


Selected publications

  • Hu KH, Eichorst JP, McGinnis CS, Patterson DM, Chow ED, Kersten K, Jameson SC, Gartner ZJ, Rao AA, Krummel MF. ZipSeq: barcoding for real-time mapping of single cell transcriptomes. 2020 Nat Methods doi:10.1038/s41592-020-0880-2
  • Mujal AM, Krummel MF. Immunity as a continuum of archetypes. 2019 Science 364(6435):28-29
  • Binnewies M, Mujal AM, Pollack JL, Combes AJ, Hardison EA, Barry KC, Tsui J, Ruhland MK, Kersten K, Abushawish MA, Spasic M, Giurintano JP, Chan V, Daud AI, Ha P, Ye CJ, Roberts EW, Krummel MF. Unleashing type-2 dendritic cells to drive protective antitumor CD4+ T cell immunity. 2019 Cell 177(3):556-571.e16
  • Barry K., Hsu J., Broz M., Cueto F., Binnewies M., Combes A., Nelson A., Loo K., Kumar R., Rosenblum M., Alvarado M., Wolf D., Bogunovic D., Bhardwaj N., Daud A., Ha P., Ryan W., Pollack J., Samad B., Asthana S., Chan V., Krummel M.F. A Natural killer–dendritic cell axis defines checkpoint therapy–responsive tumor microenvironments. 2018 Nat Med doi: 10.1038/s41591-018-0085-8

Contact: Emma Lefrançais 

Note for visitors: Due to the COVID-19-related situation, the seminar is NOT open to persons outside the IPBS.

Link to attend the seminar:

4 May

16:00 - 17:00

Online seminar